Reverse Stock Split

Showing 6126 articles
Business

Skyworks Beats Q4 Estimates but Faces Inventory and Demand Headwinds

Skyworks Solutions (SWKS) reported stronger-than-expected Q4 revenue and profit, while issuing surprisingly upbeat near-term guidance. However, the wireless chipmaker continues to grapple with year-over-year sales declines and a notable build-up in inventory, raising questions about the sustainability of its recovery amid a cyclical industry downturn.

Business

Novo Nordisk's CagriSema Shows Superior Efficacy in Phase 3 Diabetes Trial, Bolstering Pipeline and Valuation Outlook

Novo Nordisk's combination therapy CagriSema has outperformed semaglutide in a pivotal Phase 3 trial for type 2 diabetes, significantly reducing blood sugar and weight. The strong results set the stage for regulatory discussions and reinforce the company's dominance in the metabolic treatment arena, amid heightened investor focus on its long-term growth potential.

Business

Stitch Fix's Fair Value Holds Steady at $5.25 Amid Cautious Sector Sentiment

Stitch Fix's latest financial model update maintains its fair value estimate at approximately $5.25 per share, reflecting a market narrative that balances patience with profitability concerns. As the personal styling service navigates a challenging retail environment, incremental adjustments to long-term assumptions signal cautious optimism from analysts.